| Ticker Details |
Bruker Corporation Common Stock
Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels.
|
| IPO Date: |
July 2, 2003 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$9.22B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.47 | 1.83%
|
| Avg Daily Range (30 D): |
$2.09 | 3.73%
|
| Avg Daily Range (90 D): |
$1.31 | 2.85%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.71M |
| Avg Daily Volume (30 D): |
2.41M |
| Avg Daily Volume (90 D): |
1.98M |
| Trade Size |
| Avg Trade Size (Sh.): |
89 |
| Avg Trade Size (Sh.) (30 D): |
65 |
| Avg Trade Size (Sh.) (90 D): |
64 |
| Institutional Trades |
| Total Institutional Trades: |
10,661 |
| Avg Institutional Trade: |
$2.78M |
| Avg Institutional Trade (30 D): |
$3.68M |
| Avg Institutional Trade (90 D): |
$3.81M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.36M |
| Avg Closing Trade (30 D): |
$16.41M |
| Avg Closing Trade (90 D): |
$12.17M |
| Avg Closing Volume: |
114.55K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.24
|
$.02
|
$.1
|
|
Diluted EPS
|
$-.24
|
$.02
|
$.1
|
|
Revenue
|
$3.46B
|
$823.4M
|
$977.2M
|
|
Gross Profit
|
$1.57B
|
$379.8M
|
$449.2M
|
|
Net Income / Loss
|
$-9.4M
|
$15.7M
|
$29.2M
|
|
Operating Income / Loss
|
$46.6M
|
$10.2M
|
$76.3M
|
|
Cost of Revenue
|
$1.89B
|
$443.6M
|
$528M
|
|
Net Cash Flow
|
$-50.1M
|
$-165.5M
|
$5.8M
|
|
PE Ratio
|
|
|
|
|
|
|
